(Q46548926)

23 December 2017

title

11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma (English)

1 reference

23 December 2017

author name string

Tetsuhiro Hatakeyama

1

1 reference

23 December 2017

Nobuyuki Kawai

2

1 reference

23 December 2017

Yoshihiro Nishiyama

3

1 reference

23 December 2017

Yuka Yamamoto

4

1 reference

23 December 2017

Yasuhiro Sasakawa

5

1 reference

23 December 2017

Tomotsugu Ichikawa

6

1 reference

23 December 2017

Takashi Tamiya

7

1 reference

23 December 2017

publication date

10 June 2008

1 reference

23 December 2017

number of pages

9

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

23 December 2017

volume

35

1 reference

23 December 2017

issue

11

1 reference

23 December 2017

page(s)

2009-2017

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-008-0847-5

exact match

0 references

cites work

11C-methionine PET for differential diagnosis of low-grade gliomas.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-008-0847-5

Effects of fractionated radiation on the brain vasculature in a murine model: blood-brain barrier permeability, astrocyte proliferation, and ultrastructural changes.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-008-0847-5

Methyl-[11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-008-0847-5

High L-methyl-[11C]methionine uptake in brain abscess: a PET study.

21 January 2018

1 reference

12 December 2020

Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas

1 reference

12 December 2020

11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.

1 reference

12 December 2020

Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis.

1 reference

12 December 2020

11C-methionine uptake in cerebrovascular disease: a comparison with 18F-fDG PET and 99mTc-HMPAO SPECT.

1 reference

12 December 2020

[18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors

1 reference

12 December 2020

Increased amounts of D-enantiomer dependent on alkaline concentration in the synthesis of L-[methyl-11C]methionine

1 reference

12 December 2020

Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.

1 reference

12 December 2020

Evaluation of primary brain tumors with FLT-PET: usefulness and limitations.

1 reference

12 December 2020

Carbon-11-methionine PET evaluation of intracerebral hematoma: distinguishing neoplastic from non-neoplastic hematoma.

1 reference

12 December 2020

Basis of FLT as a cell proliferation marker: comparative uptake studies with [3H]thymidine and [3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines

1 reference

12 December 2020

Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma

1 reference

12 December 2020

Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine.

1 reference

12 December 2020

Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.

1 reference

12 December 2020

Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy

1 reference

12 December 2020

[18F]FLT-PET in oncology: current status and opportunities

1 reference

12 December 2020

Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas

1 reference

12 December 2020

Evaluation of the malignancy of glioma using 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining.

1 reference

12 December 2020

18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.

1 reference

12 December 2020

Positron emission tomography with injection of methionine as a prognostic factor in glioma

1 reference

12 December 2020

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

1 reference

12 December 2020

Potential significance of (11)C-methionine PET as a marker for the radiosensitivity of low-grade gliomas

1 reference

12 December 2020

Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value

1 reference

12 December 2020

Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.

1 reference

12 December 2020

Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma.

1 reference

12 December 2020

Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study

1 reference

12 December 2020

Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.

1 reference

12 December 2020

[11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence.

1 reference

12 December 2020

The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.

1 reference

12 December 2020

Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma

1 reference

12 December 2020

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

1 reference

12 December 2020

Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study

1 reference

12 December 2020

10.1007/S00259-008-0847-5

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017